CABALETTA BIO, INC.

CABA ·Healthcare, Drug Manufacturers - General, United States
Balance Sheet › Asset & Liabilities Breakdown

Asset & Liabilities Breakdown

Asset Breakdown FY2023

Total Assets: $253.7M

Liabilities Breakdown FY2023

Total Liabilities: $17.5M